205 related articles for article (PubMed ID: 15645343)
1. Postnatal decrease in substantia nigra echogenicity. Implications for the pathogenesis of Parkinson's disease.
Iova A; Garmashov A; Androuchtchenko N; Kehrer M; Berg D; Becker G; Garmashov Y
J Neurol; 2004 Dec; 251(12):1451-4. PubMed ID: 15645343
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
[TBL] [Abstract][Full Text] [Related]
3. In vivo detection of iron and neuromelanin by transcranial sonography--a new approach for early detection of substantia nigra damage.
Berg D
J Neural Transm (Vienna); 2006 Jun; 113(6):775-80. PubMed ID: 16755382
[TBL] [Abstract][Full Text] [Related]
4. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease.
Ruprecht-Dörfler P; Berg D; Tucha O; Benz P; Meier-Meitinger M; Alders GL; Lange KW; Becker G
Neuroimage; 2003 Feb; 18(2):416-22. PubMed ID: 12595195
[TBL] [Abstract][Full Text] [Related]
5. Hyperechogenicity of the substantia nigra in Parkinson's disease.
Ressner P; Skoloudík D; Hlustík P; Kanovský P
J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838
[TBL] [Abstract][Full Text] [Related]
6. Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease.
Schweitzer KJ; Brüssel T; Leitner P; Krüger R; Bauer P; Woitalla D; Tomiuk J; Gasser T; Berg D
J Neurol; 2007 May; 254(5):613-6. PubMed ID: 17415511
[TBL] [Abstract][Full Text] [Related]
7. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury.
Berg D; Roggendorf W; Schröder U; Klein R; Tatschner T; Benz P; Tucha O; Preier M; Lange KW; Reiners K; Gerlach M; Becker G
Arch Neurol; 2002 Jun; 59(6):999-1005. PubMed ID: 12056937
[TBL] [Abstract][Full Text] [Related]
8. Substantia nigra echogenicity is associated with serum ferritin, gender and iron-related genes in Parkinson's disease.
Li K; Ge YL; Gu CC; Zhang JR; Jin H; Li J; Cheng XY; Yang YP; Wang F; Zhang YC; Chen J; Mao CJ; Liu CF
Sci Rep; 2020 May; 10(1):8660. PubMed ID: 32457446
[TBL] [Abstract][Full Text] [Related]
9. Severity of restless legs syndrome is inversely correlated with echogenicity of the substantia nigra in different neurodegenerative movement disorders. a preliminary observation.
Pedroso JL; Bor-Seng-Shu E; Felicio AC; Braga-Neto P; Dutra LA; de Aquino CC; Ferraz HB; do Prado GF; Teixeira MJ; Barsottini OG
J Neurol Sci; 2012 Aug; 319(1-2):59-62. PubMed ID: 22632781
[TBL] [Abstract][Full Text] [Related]
10. Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker.
Berg D; Hochstrasser H; Schweitzer KJ; Riess O
Neurotox Res; 2006 Jan; 9(1):1-13. PubMed ID: 16464747
[TBL] [Abstract][Full Text] [Related]
11. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
[TBL] [Abstract][Full Text] [Related]
12. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.
Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545
[TBL] [Abstract][Full Text] [Related]
13. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.
Walter U; Wittstock M; Benecke R; Dressler D
J Neural Transm (Vienna); 2002 Feb; 109(2):191-6. PubMed ID: 12075859
[TBL] [Abstract][Full Text] [Related]
14. Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.
Toomsoo T; Liepelt-Scarfone I; Berg D; Kerner R; Pool AH; Kadastik-Eerme L; Rubanovits I; Asser T; Taba P
Ultrasound Med Biol; 2019 Jan; 45(1):122-128. PubMed ID: 30482710
[TBL] [Abstract][Full Text] [Related]
15. Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.
Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Tan YY; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Chen SD
J Parkinsons Dis; 2018; 8(2):333-340. PubMed ID: 29614699
[TBL] [Abstract][Full Text] [Related]
16. [Transcranial sonography of substantia nigra in patients with Parkinson's disease].
Miwa H
Rinsho Shinkeigaku; 2013; 53(11):981-2. PubMed ID: 24291852
[TBL] [Abstract][Full Text] [Related]
17. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.
Mahlknecht P; Seppi K; Stockner H; Nocker M; Scherfler C; Kiechl S; Willeit J; Schmidauer C; Gasperi A; Rungger G; Poewe W
Neurodegener Dis; 2013; 12(4):212-8. PubMed ID: 23689066
[TBL] [Abstract][Full Text] [Related]
18. Plasma ceruloplasmin ferroxidase activity correlates with the nigral sonographic area in Parkinson's disease patients: a pilot study.
Martínez-Hernández R; Montes S; Higuera-Calleja J; Yescas P; Boll MC; Diaz-Ruiz A; Rios C
Neurochem Res; 2011 Nov; 36(11):2111-5. PubMed ID: 21706376
[TBL] [Abstract][Full Text] [Related]
19. Substantia nigra hyperechogenicity does not correlate with motor features in Parkinson's disease.
Jesus-Ribeiro J; Sargento-Freitas J; Sousa M; Silva F; Freire A; Januário C
J Neurol Sci; 2016 May; 364():9-11. PubMed ID: 27084206
[TBL] [Abstract][Full Text] [Related]
20. Transcranial brain sonography in Parkinson's disease with restless legs syndrome.
Kwon DY; Seo WK; Yoon HK; Park MH; Koh SB; Park KW
Mov Disord; 2010 Jul; 25(10):1373-8. PubMed ID: 20544813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]